InvestorsHub Logo
Followers 90
Posts 17892
Boards Moderated 0
Alias Born 09/06/2006

Re: Guzzi62 post# 665942

Monday, 01/22/2024 3:43:34 PM

Monday, January 22, 2024 3:43:34 PM

Post# of 724257

Another competitor but far behind us, using almost same approach as I understand it,


Kind of odd that people keep calling any ATL-DC the same as NWBO's

There have been dozens (maybe hundreds) of ATl-DC trials. Longs here argue (and potentially with merit) that NWBO has somehow done it better. But then they say anything else is just the same.

The Elios TLPODC concept is clearly different in how the ATL-DC is manufactured. But still in the same class as DC-L.

The Elios TLPO concept though is not even an ATL-DC. It is a very different product. It takes the lysate, encapsulated in particle that uses yeast cell wall lining to enclose it, and injects that into the patient. The idea is that the DC's (and other APCs) will recognize and react to it n vivo, as God designed..

I nether know nor care how it actually works. But the idea that all ATL-DC's are NWBO clones is just funny when NWBO was not the first and in no way owns the space.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News